Sponsors (23)
The bill aims to strengthen antimicrobial R&D, stewardship, and preparedness—improving access and national readiness for resistant infections—while raising federal costs and creating risks of higher drug prices, administrative burdens, and allocation tensions during shortages.
Patients (including those with chronic or drug-resistant infections) could gain greater access to effective antimicrobials because the bill promotes R&D, market access, and availability of lifesaving medicines.
Hospitals, health systems, and clinicians could receive new tools, programs, and guidance to prevent and treat drug-resistant infections, improving patient safety and infection control.
Scientists, researchers, and the biomedical sector could get increased federal support and incentives for antimicrobial R&D and diagnostics, accelerating development of new therapies.
Taxpayers could face increased federal spending to support R&D, market-access programs, and preparedness measures if the bill creates new funding without offsets.
Patients could face higher drug costs if the bill’s incentives or procurement approaches favor private firms or do not preserve price protections.
Clinicians, hospitals, and state public‑health agencies could face added regulatory complexity and administrative burdens from new programs, reporting, or procurement requirements.
Based on analysis of 3 sections of legislative text.
Adds a new statutory provision to promote development, availability, stewardship, and preparedness for antimicrobials by inserting a "Developing antimicrobial innovations" program into Title III of the Public Health Service Act.
Introduced February 4, 2026 by Buddy Carter · Last progress February 4, 2026
Creates a new federal authority to support development and availability of lifesaving antimicrobial medicines by adding a new "Developing antimicrobial innovations" provision to the Public Health Service Act. It states goals to stimulate research and market access for antimicrobials, promote appropriate clinical use and stewardship, maintain health care standards, improve health system preparedness, and support national defense and military needs. The text of the new program itself is not included in the provided excerpt, so funding levels, program design, deadlines, and specific requirements are not available.